B-HCG Levels in Women Diagnosed With Retained Products of Conception

Status Completed

Clinical Trial Summary

Retained Products of Conception (RPOC) is a condition where gestational tissue remains in the uterus after birth or after a surgical or medical abortion. This condition may cause significant bleeding, infection, and long-term intrauterine adhesions associated with fertility problems and pregnancy complications (Asherman's syndrome). RPOC are diagnosed according to the clinical and ultrasound findings (such as an echogenic foci in the uterine cavity with Doppler blood flows). However, the diagnosis of RPOC by clinic and ultrasound characteristics is inaccurate and false positive results are reported in up to 40% of women undergoing a surgical procedure for RPOC removal (most often by hysterosocpy). However, surgery also carries a risk of complications and intrauterine infections. Therefore, the need arises for additional tools to improve the diagnosis available today in order to minimize the need for surgical procedures as much as possible. The production and secretion of the B-HCG occurs in the placenta and begins after blastocyst implantation. The B-HCG levels increase in other placental pathologies such as gestational trophoblastic disease (GTD). Accordingly, the investigators hypothesized that in cases of placental remnants a secretion of B-HCG may be detected and quantified. In this prospective, non-interventional study the investigators' aim is to examine whether B-HCG can be used as a marker for detecting placental remnants, compared to the currently accepted sonographic method. For this purpose, the investigators will examine the levels of B-HCG in participants undergoing hysteroscopy for removal of RPOC.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Retained Products of Conception

Clinical Trial Details

NCT number	NCT04917016
Study type	Observational
Source	Assaf-Harofeh Medical Center
Contact
Status	Completed
Phase
Start date	December 1, 2019
Completion date	February 28, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05811286` - The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study	N/A
Recruiting	`NCT04804332` - Removal of Intrauterine Retained Products of Conception (RPOC) After Miscarriage Guided by Hysteroscopy Trial. A Randomized Controlled Trial.	N/A
Recruiting	`NCT04637373` - Hysteroscopy Assisted Suction Curettage for Early Pregnancy Loss	N/A
Recruiting	`NCT04705324` - Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion	N/A
Recruiting	`NCT06009679` - MISOPROSTOL FOR THE TREATMENT OF SUSPECTED POSTPARTUM RETAINED PRODUCTS OF CONCEPTION	N/A
Recruiting	`NCT05722028` - Predictive Factors for Successful Operative Hysteroscopy Using Tissue Removal Device (TruClear System) Without Anesthesia
Recruiting	`NCT05085067` - The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception	N/A
Active, not recruiting	`NCT03880435` - HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant	N/A